About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

67.77 -1.35 (-1.95%)
Streaming Delayed Price Updated: 11:18 AM EDT, Sep 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Jim Cramer Praises PayPal CEO Alex Chriss: 'Financial Techs Have Come Back In Style' ↗
PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more. 
Via Benzinga
News headline image
These Analysts Cut Their Forecasts On Liquidia ↗
 
Via Benzinga
News headline image
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge ↗
 
Via Benzinga
News headline image
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why Liquidia Corporation Shares Are Moving Lower Monday ↗
Liquidia announced that the Food and Drug Administration granted tentative approval of YUTREPIA. 
Via Benzinga
News headline image
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher ↗
 
Via Benzinga
News headline image
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38% ↗
The company is hoping to launch a drug that rivals United Therapeutics' Tyvaso DPI. 
Via Investor's Business Daily
News headline image
LQDA Investors Have Opportunity to Join Liquidia Corporation Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Expert Ratings For Liquidia ↗
 
Via Benzinga
News headline image
Expert Outlook: Liquidia Through The Eyes Of 5 Analysts ↗
 
Via Benzinga
News headline image
Forecasting The Future: 5 Analyst Projections For Liquidia ↗
 
Via Benzinga
News headline image
7 Analysts Have This To Say About Liquidia ↗
 
Via Benzinga
News headline image
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q2 2024 ↗
LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
From Liquidia Corporation
Via GlobeNewswire
News headline image
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics ↗
Liquidia stock retook its 50-day line Monday on a U.S. judge's ruling on a patent dispute with fellow biotech company United Therapeutics. 
Via Investor's Business Daily
Topics Intellectual Property
News headline image
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
From Liquidia Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024 ↗
LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.